Selecting appropriate expression systems for large-scale production of lead antibodies
17 Jun 2024
Salon B
Lead Identification & Optimization
- Agonistic antibodies to checkpoint inhibitors – how to select the best epitope and achieve engagement in the immune synapse?
- Agonistic bispecific antibodies to cytokine receptors – how to achieve specificity and selectivity?
- Which antibody formats are best suited for agonistic antibodies?
- Can a non-neutralizing antibody to a cytokine/ soluble target be used to increase its serum half-life and activity?
